A Phase 2a Study of Foralumab Nasal in Patients With Multiple System Atrophy (MSA)

Abroad (travel likely)RecruitingPHASE2

Conditions

Multiple System Atrophy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Brigham and Women's Hospital, Boston, Massachusetts, United States

    Contact: Study coordinator (BWH Movement Disorders Research Group) · BWHMovementResearch@bwh.harvard.edu · 857-307-542
    Contact: Principal Investigator (Vikram Khurana, MD, PhD)